Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu (Q40681120)

From Wikidata
Jump to navigation Jump to search
scientific article published on September 1995
edit
Language Label Description Also known as
English
Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu
scientific article published on September 1995

    Statements

    Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu (English)
    F H Valone
    P A Kaufman
    P M Guyre
    L D Lewis
    V Memoli
    R Graziano
    J L Fisher
    L Meyer
    M Mrozek-Orlowski
    1 September 1995
    2281-2292

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit